Robert Azelby insider trades: ADC Therapeutics (ADCT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Robert reports to the SEC
and 6 more companies
Open-market buys and sales
11 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | ADCT | ↓ Sell | 6,995 | $2.89 | $20K | Direct | Jun 18, 2024 (1d) |
| Feb 12, 2018 | JUNO | ↓ Sell10b5-1 | 4,157 | $85.55 | $356K | Direct | Feb 14, 2018 (2d) |
| Feb 8, 2018 | JUNO | ↓ Sell10b5-1 | 3,497 | $85.77 | $300K | Direct | Feb 9, 2018 (1d) |
| Feb 1, 2018 | JUNO | ↓ Sell10b5-1 | 4,167 | $85.78 | $357K | Direct | Feb 2, 2018 (1d) |
| Jan 22, 2018 | JUNO | ↓ Sell10b5-1 | 102,539 | $86.25 | $8.8M | Direct | Jan 24, 2018 (2d) |
| Jan 17, 2018 | JUNO | ↓ Sell10b5-1 | 29,131 | $68.61 | $2.0M | Direct | Jan 19, 2018 (2d) |
| Dec 18, 2017 | JUNO | ↓ Sell10b5-1 | 1,816 | $44.96 | $82K | Direct | Dec 20, 2017 (2d) |
| Nov 2, 2017 | JUNO | ↓ Sell10b5-1 | 6,666 | $54.95 | $366K | Direct | Nov 3, 2017 (1d) |
| Sep 13, 2017 | JUNO | ↓ Sell10b5-1 | 12,850 | $44.95 | $578K | Direct | Sep 14, 2017 (1d) |
| Aug 29, 2017 | JUNO | ↓ Sell10b5-1 | 12,869 | $39.95 | $514K | Direct | Aug 31, 2017 (2d) |
| Nov 10, 2016 | JUNO | ↓ Sell10b5-1 | 12,921 | $24.14 | $312K | Direct | Nov 10, 2016 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ADCT insiders
Open-market trades in the last 12 months
About Robert Azelby's insider trades
Robert Azelby is a director at ADC Therapeutics (ADCT). Since Nov 10, 2016, Robert has reported no open-market purchases and 11 sales worth $13.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
10 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (29 filings), shares returned to the company (6 filings), option exercises (5 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADCT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.